Browse the full Event Guide to discover:
- in-vitro & in-vivo action: Challenges & opportunities in preclinical research of synthetic cannabinoids for pain therapy
- Where’s, What’s & How’s of cannabinoid clinical trials to minimize placebo effect and produce scientifically robust evidence
- Regulatory implications and navigating the FDA process to create an ethical cannabinoid drug: Implications of early critical choices
- Case study on novel cannabinoid receptor 2 (CB2) agonist and accessing the potential of CB2 activation to treat systemic sclerosis
- Battle of synthetic cannabinoids vs natural cannabinoids: Discuss ‘the entourage effect’ referring to the synergistic interaction between different cannabinoids
